The team at Huntington’s Disease News covered the latest community developments and updates in research related to Huntington’s disease throughout…
Articles by Marisa Wexler, MS
The California Institute for Regenerative Medicine (CIRM) — a state agency created to advance novel treatments for serious medical…
Certain antipsychotic medications, including the Huntington’s approved therapy tetrabenazine (sold as Xenazine in the U.S., with generics available), significantly…
Complex fatty molecules called gangliosides are key to the formation of cellular shipping containers that help brain nerve cells get…
Researchers in China have developed a new system to grow the specific type of brain cells that are lost in…
Three years of treatment with Ingrezza (valbenazine) led to rapid and sustained reductions in the severity of uncontrolled movements…
Up to two years of pridopidine treatment continues to slow Huntington’s disease progression among patients not taking certain…
Available evidence does not indicate that treatments approved for people with Alzheimer’s disease can improve cognitive function in people with…
uniQure’s experimental gene therapy AMT-130 safely and effectively slows the progression of Huntington’s disease, according to top-line, three-year…
Three months of daily treatment with Skyhawk Therapeutics’ oral candidate SKY-0515 safely and effectively reduced blood levels of…